Department of Internal Medicine and Pediatrics
, Department of Pediatrics and medical genetics
, Eli Lilly (United Kingdom), Janssen (Belgium), Children's Memorial Health Institute, Charles University, Bayer (Germany), Sant Joan de Déu Research Foundation, Hospital District of Helsinki and Uusimaa, Roche (Switzerland), Novartis (Switzerland), Haukeland University Hospital, Newcastle University, Helios Dr. Horst Schmidt Kliniken Wiesbaden, Madrid Health Service, University of Tartu, Aristotle University of Thessaloniki, UCB Pharma (Belgium), Radboud University Nijmegen, GlaxoSmithKline (United Kingdom), Bambino Gesù Children's Hospital, Pfizer (United Kingdom), University of Cagliari, European Clinical Research Infrastructure Network, University of Liverpool, University Hospital Heidelberg, University College Cork, Servicio Gallego de Salud, Inserm, Karolinska Institute, Sanofi (France), Istituto Giannina Gaslini
c4c (conect4children) is a large collaborative European network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population.
It is a pioneering opportunity to build capacity for the implementation of multinational paediatric clinical trials whilst ensuring the needs of babies, children, young people and their families are met.